Aktive Positionen von Philipp Bürling
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
NUMAFERM GmbH
 NUMAFERM GmbH BiotechnologyHealth Technology NUMAFERM GmbH specializes in the biotechnical production of peptides. The firm focuses on pharmaceutical, antimicrobial and adhesives peptides. Its services include feasibility study, custom synthesis, peptide development, up scaling, and licensing services. The company was founded by Philipp Bürling and Karl Christian Werner Schwarz in January 2017 and is headquartered in Dusseldorf, Germany. | Finanzdirektor/CFO | 01.01.2017 | - |
| Gründer | 01.01.2017 | - | |
Priavoid GmbH
 Priavoid GmbH Pharmaceuticals: MajorHealth Technology Priavoid GmbH develops therapies for neurological diseases. The company is based in Düsseldorf, Germany. The German company was founded in 2017. The CEO is Philipp Bürling. | Vorstandsvorsitzender | - | - |
Karriereverlauf von Philipp Bürling
Statistik
International
| Deutschland | 3 |
Operativ
| Director of Finance/CFO | 1 |
| Founder | 1 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
NUMAFERM GmbH
NUMAFERM GmbH BiotechnologyHealth Technology NUMAFERM GmbH specializes in the biotechnical production of peptides. The firm focuses on pharmaceutical, antimicrobial and adhesives peptides. Its services include feasibility study, custom synthesis, peptide development, up scaling, and licensing services. The company was founded by Philipp Bürling and Karl Christian Werner Schwarz in January 2017 and is headquartered in Dusseldorf, Germany. | Health Technology |
Priavoid GmbH
Priavoid GmbH Pharmaceuticals: MajorHealth Technology Priavoid GmbH develops therapies for neurological diseases. The company is based in Düsseldorf, Germany. The German company was founded in 2017. The CEO is Philipp Bürling. | Health Technology |
- Börse
- Insiders
- Philipp Bürling
- Erfahrung
